You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API clozapine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing clozapine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Teva Pharmaceuticals USA Inc CLOZAPINE clozapine 0093-3011 ASPARTAME
Teva Pharmaceuticals USA Inc CLOZAPINE clozapine 0093-3011 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc CLOZAPINE clozapine 0093-3011 CITRIC ACID MONOHYDRATE
Teva Pharmaceuticals USA Inc CLOZAPINE clozapine 0093-3011 CROSPOVIDONE
Teva Pharmaceuticals USA Inc CLOZAPINE clozapine 0093-3011 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Teva Pharmaceuticals USA Inc CLOZAPINE clozapine 0093-3011 FERRIC OXIDE YELLOW
Teva Pharmaceuticals USA Inc CLOZAPINE clozapine 0093-3011 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing clozapine

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc clozapine 0093-4359 LACTOSE MONOHYDRATE
Teva Pharmaceuticals USA Inc clozapine 0093-4359 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc clozapine 0093-4359 POVIDONE K90
Teva Pharmaceuticals USA Inc clozapine 0093-4359 SILICON DIOXIDE
Teva Pharmaceuticals USA Inc clozapine 0093-4359 STARCH, CORN
Teva Pharmaceuticals USA Inc clozapine 0093-4359 TALC
Teva Pharmaceuticals USA Inc clozapine 0093-5376 ASPARTAME
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for clozapine

Excipient focus: ASPARTAME

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSPOVIDONE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

clozapine drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
Teva Pharmaceuticals USA Inc clozapine 0093-4359
Teva Pharmaceuticals USA Inc clozapine 0093-5376
Teva Pharmaceuticals USA Inc clozapine 0093-5416
Mylan Pharmaceuticals Inc clozapine 0378-0825
Mylan Pharmaceuticals Inc clozapine 0378-3813
Sandoz Inc clozapine 0781-5989
Major Pharmaceuticals clozapine 0904-7089
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERIN

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN SODIUM

Excipient focus: MINERAL OIL

Excipient focus: MINT

Excipient focus: PEPPERMINT

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: POVIDONES

Excipient focus: PROPYLPARABEN SODIUM

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Excipient focus: XYLITOL

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group